期刊文献+

肝硬化并发上消化道出血的危险因素分析 被引量:13

Analysis of risk factor of cirrhosis complicated with upper gastrointestinal bleeding
下载PDF
导出
摘要 目的 了解肝硬化并发上消化道出血的相关危险因素,为预防和控制疾病提供可靠的依据。方法 对130例肝硬化患者进行病例对照研究。结果 肝硬化并发上消化道出血与食道静脉曲张(0R =3. 94 2 ,P =0 . 0 0 1)、肝功能分级(0R =1 .0 2 8,P =0 .0 0 3)、门脉高压性胃病(0R =3. 86 2 ,P =0 .0 0 2 )有显著性关系。结论 肝硬化并发上消化道出血的危险因素是食道静脉曲张、肝功能分级、门静脉内径、门脉高压性胃病。 Objective To study risk factor of cirrhosis complicated with upper gastrointestinal bleeding in order to supply reliable basis for preventing and controlling disease. Method 120 cirrhosis patients were studied by case-control study. Results Cirrhosis with complicated upper gastrointestinal bleeding had noticeably connections with factors of esophagus venous bleeding(0R=3.942, P =0.001),liver function grade(OR=1.028, P =0.003), portal vein high pressure stomach trouble(OR=3.862, P =0.002).Conclusion Risk factor of cirrhosis yuith complicated upper gastrointestinal bleeding is esophagus venous bleeding,liver function grade,portal vein high pressure stomach trouble respectively.
出处 《中国急救医学》 CAS CSCD 北大核心 2005年第5期320-321,共2页 Chinese Journal of Critical Care Medicine
关键词 肝硬化 门脉高压 上消化道出血 危险因素 Cirrhosis Portal vein high pressure Upper gastrointestinal bleeding Risk factor
  • 相关文献

参考文献6

二级参考文献12

  • 1段丽萍 梁扩寰 等.门静脉高压症的内镜诊断.门静脉高压症[M].北京:人民卫生出版社,1999.277-283.
  • 2[1]Johanson JF, Siddique R, Damiano AM, Jokubaitis L,Murthy A, Bhattacharjya A. Rabeprazole improves healthelated quality of life in patients with erosive gastroesophageal reflux disease. Dig Dis Sci, 2002, 47: 2574~2578.
  • 3[2]Skoczylas T, Sarosiek l, Sostarich S, McElhinney C, Durham S, Sarosiek J. Significant enhancement of gastric mucin content after rabeprazole administration: its poten tial clinical significance in acid-related disorders. Dig DisSci, 2003, 48: 322~328.
  • 4[3]Knaus WA, Draper EA, Wagner DP, Zimmerman JE. APACHE Ⅱ: a severity of disease classification system. Crit Care Med, 1985, 13: 818~829.
  • 5[4]Ranson JH, Rifkind KM, Roses DF, Fink SD, Eng K, Spencer FC. Prognostic signs and the role of operative management in acute pancreatitis. Surg Gynecol Obstet, 1974, 139: 69~81.
  • 6[5]Balthazar EJ, Robinson DL, Megibow AJ, Ranson JH. Acute pancreatitis: value of CT in establishing prognosis. Radiology, 1990, 174: 331~336.
  • 7[6]Lin CK, Wang ZS, Lai KH, Lo GH, Hsu PI. Gastrointestinal mucosal lesions in patients with acute pancreati tis. Zhonghua Yi Xue Za Zhi (Taipei), 2002, 65: 275~ 278.
  • 8[7]Tryba M. Role of acid suppressants in intensive care medic ine. Best Pract Res Clin Gastroenterol, 2001, 15: 447~461.
  • 9[8]Steinberg KP. Stress-related mucosal disease in the crit ically ill patient: risk factors and strategies to prcvent stress-related bleeding in the intensive care unit. Crit Care Med, 2002, 30 (6 Suppl): S362~S364.
  • 10[9]Freedman MD. Stress ulcer prevention and histamine-2 receptor antagonists: leaps of faith or back to the drawing board? Crit Care Med, 1999, 27: 13~14.

共引文献14039

同被引文献95

引证文献13

二级引证文献92

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部